Latest news with #FLEX
Business Wire
24-07-2025
- Business
- Business Wire
Chervon Selects Blue Yonder To Elevate Demand Forecasting and Customer Service
NANJING, China & DALLAS--(BUSINESS WIRE)--From global tariff concerns to highly volatile demand, manufacturers are facing unprecedented challenges and uncertainty. That's why Chervon, a global leader in power tools and outdoor power equipment, has selected Blue Yonder to transform its planning processes and increase customer satisfaction. Chervon will deploy Blue Yonder's demand and replenishment capabilities, supported by Shanghai Compass Information and Science Co., Ltd., a Blue Yonder partner. Founded in 1993, Chervon designs and manufactures a wide range of tools, including handheld power tools, bench tools and outdoor power equipment. Its products, which include popular brands such as EGO, FLEX and SKIL, are sold in over 100 countries worldwide. With a growing multi-channel sales and distribution network and a constantly changing business landscape, Chervon turned to Blue Yonder to improve its forecasting and increase efficiency across its global operations. With Blue Yonder, Chervon will be able to: Increase forecast accuracy to ensure the right products are available in the right place at the right time. Automate routine planning tasks to increase efficiency and labor productivity. Achieve cross-functional collaboration to improve decision-making across the organization. Dynamically adjust inventory to align with actual demand, minimizing stockouts and overstock while increasing customer satisfaction. With Blue Yonder's cloud-based demand and replenishment capabilities, Chervon will be able to quickly and accurately respond to demand fluctuations and optimize inventory levels. This will allow Chervon to increase customer satisfaction and operational efficiency while also reducing waste and costs across its global network. 'In today's complex, global supply chain environment, speed and precision are crucial for meeting customer expectations and adapting to rapidly changing conditions,' said Antonio Boccalandro, president, APAC, Blue Yonder. 'Our demand and replenishment capabilities will enable Chervon to improve and accelerate decision-making and build a more resilient and efficient supply chain.' About Blue Yonder Blue Yonder is the world leader in end-to-end digital supply chain transformation. With a unified, AI-driven platform and multi-tier network, Blue Yonder empowers businesses to operate sustainably, scale profitably, and delight their customers — all at machine speed. A pioneer in applying AI solutions to the most complicated supply chain challenges, Blue Yonder's modern innovations and unmatched industry expertise help more than 3,000 retailers, manufacturers, and logistics service providers confidently navigate supply chain complexity and disruption. 'Blue Yonder' is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name 'Blue Yonder' is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.
Yahoo
11-07-2025
- Business
- Yahoo
Flex's Q1 Earnings Call: Our Top 5 Analyst Questions
Flex's first quarter results were met with a positive market response, driven by strong execution in its data center and cloud businesses and a sustained focus on operational efficiency. CEO Revathi Advaithi credited the nearly 4% year-over-year revenue growth to 'multiple program ramps' and the company's ability to shift its portfolio toward higher-value, margin-accretive segments. Management highlighted the success of its Flex Forward strategy in building a more resilient business, with adjusted operating margin reaching a record level, supported by disciplined cost control and a diversified end-market approach. Is now the time to buy FLEX? Find out in our full research report (it's free). Revenue: $6.40 billion vs analyst estimates of $6.23 billion (3.7% year-on-year growth, 2.6% beat) Adjusted EPS: $0.73 vs analyst estimates of $0.69 (5.2% beat) Adjusted EBITDA: $534 million vs analyst estimates of $514.1 million (8.3% margin, 3.9% beat) Revenue Guidance for Q2 CY2025 is $6.25 billion at the midpoint, below analyst estimates of $6.36 billion Adjusted EPS guidance for the upcoming financial year 2026 is $2.91 at the midpoint, beating analyst estimates by 1.8% Operating Margin: 4.8%, up from 2.6% in the same quarter last year Market Capitalization: $19.41 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Samik Chatterjee (JP Morgan) asked about the drivers behind strong margin guidance, to which CFO Kevin Krumm pointed to ongoing mix improvement from cloud and power, as well as growth in services and operational efficiency. Steven Fox (Fox Advisors) questioned Flex's scale advantages in data centers and inventory trends; CEO Revathi Advaithi detailed Flex's vertically integrated IT integration and engineering capabilities as unique differentiators, while Krumm discussed inventory normalization and targeted free cash flow conversion. Ruplu Bhattacharya (Bank of America) sought clarity on the sustainability of 30% data center growth and customer diversification, with Advaithi highlighting a broad hyperscaler and enterprise mix, and Krumm explaining margin benefits from customer-sourced inventory models. George Wang (Barclays) inquired about sequential margin step-down and networking share gains. Krumm attributed lower Q2 margins to seasonality and auto market softness, while Advaithi described networking growth as broad-based across geographies and customers. Mark Delaney (Goldman Sachs) pressed on the potential impact of tariffs on margins and demand, receiving confirmation from management that tariffs are expected to be pass-through with limited impact on operating profit, though some margin drag is possible if tariff levels persist. The StockStory team will be monitoring (1) Flex's ability to sustain rapid data center and power segment growth despite broader market volatility, (2) the company's execution on North American and European capacity expansions in response to regionalization trends, and (3) the impact of evolving trade and tariff policies on both customer demand and cost structure. Progress in value-added services and successful integration of recent acquisitions will also be key signposts. Flex currently trades at $52.38, up from $36.74 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
USA Today
03-07-2025
- Business
- USA Today
Roxon Inc. Launches Mini Flex Companion and Modular Gear Bundles for Outdoor Enthusiasts
Roxon Inc., a leader in modular everyday carry tools, launches the Mini Flex Companion, a compact addition to its innovative multitool lineup, alongside new bundle deals for their innovative modular system. The Mini Flex Companion brings full-sized functionality in a miniature, customizable multitool designed for campers, hikers, and EDC enthusiasts. The Roxon Mini Flex Companion is a much-anticipated modular multitool built for ultra-portable use. Despite its small frame, it retains the signature Flex system's swappable implements and versatility. This pocket-sized tool is ideal for ultralight backpackers, outdoor adventurers, and everyday carry (EDC) fans who want a smaller form factor without sacrificing functionality. In addition to the Flex Mini launch, Roxon is introducing two new bundle kits that offer the opportunity to buy the modular tools at a discounted price (10% OFF). These new bundles include: Roxon Inc. is a pioneer in multi-functional outdoor gear, offering a wide range of modular and pre-installed multitools. Known for quality engineering and innovative design, Roxon's mission is to empower users with gear that adapts to their lifestyle. The company's FLEX series of multitools and accessories has redefined versatility for everyday carry and outdoor applications, allowing users to customize their tool loadout for any adventure. Media Contact: Neha More | ROXON Inc. sales@ | +1 (949) 781-0132 SOURCE: ROXON Inc. View the original press release on ACCESS Newswire
Yahoo
13-06-2025
- Business
- Yahoo
Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis
Chicago, IL – June 13, 2025 – Stocks in this week's article are Flex Ltd. FLEX, CVS Health CVS, Urban Outfitters URBN and Exelixis EXEL. In the equity market, investments always need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether one should resort to a value strategy that seeks discounted stocks or opt for growth investing in times of extreme market instability. The investing track of the Oracle of Omaha over the past few decades and his gradual shift from being a pure-play value investor to a GARP (growth at a reasonable price) investor might give us all the answers. Several stocks that have surged significantly in the recent past show an overwhelming success of this hybrid investing strategy over pure-play value and growth investments. Here, we will discuss the success of four such stocks. These are Flex Ltd., CVS Health, Urban Outfitters and Exelixis. The GARP theory enables strategic mingling of growth and value-investing principles, which gives us a hybrid strategy by utilizing the best features of both. What GARPers look for is whether or not the stocks are somewhat undervalued and have solid, sustainable growth potential (Investopedia). GARP investing gives priority to one of the popular value metrics — the price/earnings growth (PEG) ratio. Although it is categorized under value investing, this strategy follows the principles of both growth and value investing. The PEG ratio is defined as (Price/ Earnings)/Earnings Growth Rate It relates stocks' P/E ratio with their future earnings growth rates. While P/E alone gives an idea of stocks that are trading at a discount, PEG, while adding the growth element to it, helps identify stocks with solid future potential. A lower PEG ratio, preferably less than 1, is always better for GARP investors. Say, for example, if a stock's P/E ratio is 10 and the expected long-term growth rate is 15%, the company's PEG will come down to 0.66, a ratio indicating both undervaluation and future growth potential. Unfortunately, this ratio is often neglected due to investors' limitations in calculating the future earnings growth rate of a stock. There are some drawbacks to using the PEG ratio though. It does not consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term. Hence, PEG-based investing can be even more rewarding if some other relevant parameters are also taken into consideration. Here are the four stocks that qualified the screening: Flex: This Singapore-based company has a diverse workforce across 30 countries and offers advanced manufacturing solutions and additional value to customers through a wide array of services, including design and engineering, component services, rapid prototyping, fulfilment, and circular economy solutions. Flex is gaining from a growing intellectual property (IP) portfolio, new design wins and strategic acquisitions. FLEX stock can be an impressive GARP investment pick with its Zacks Rank #2 and a Value Score of A. Apart from a discounted PEG and P/E, Flex also has an impressive long-term historical earnings growth rate of 35.1%. You can see the complete list of today's Zacks #1 Rank stocks here. CVS Health: Headquartered in Woonsocket, RI, this is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. CVS Health is investing in advanced technological capabilities to cut down costs and improve customer experience. Improved Medicare Advantage star ratings for the 2025 payment year are a positive development for the company. CVS can also be an impressive GARP investment pick with its Zacks Rank #2 and a Value Score of A. Apart from a discounted PEG and P/E, CVS Health also has a solid long-term expected growth rate of 11.4%. Urban Outfitters: Based in Philadelphia, PA, Urban Outfitters is a lifestyle specialty retailer that offers fashion apparel and accessories, footwear, home décor and gift products. The company's merchandise is generally sold directly to consumers through stores, catalogs, call centers and e-commerce platforms. Apart from a discounted PEG and P/E, Urban Outfitters has a Value Score of A and holds a Zacks Rank #1. URBN stock also has a 20% earnings growth rate for the last five years. Exelixis: This Alameda, CA-based oncology-focused biotechnology company primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. Exelixis has collaborations with several leading pharmaceutical companies such as Bristol-Myers Squibb, Merck and Daiichi Sankyo Company for various compounds and programs in its portfolio. The stock can be an impressive value investment pick with its Zacks Rank #2 and a Value Score of B. Apart from a discounted PEG and P/E, the stock also has an impressive long-term expected earnings growth rate of 21.2%. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit at: Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. Follow us on Twitter: Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS) : Free Stock Analysis Report Urban Outfitters, Inc. (URBN) : Free Stock Analysis Report Exelixis, Inc. (EXEL) : Free Stock Analysis Report Flex Ltd. (FLEX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Health Line
12-06-2025
- Health
- Health Line
Stress Can Cause Spotting — Here's Why It Happens and What to Do
Stress can spike cortisol levels, disrupting the body's production of sex hormones like estrogen. This can result in spotting and other menstrual changes. Spotting generally occurs as small droplets of blood in your underwear or as a pink, red, or brown tinge in your discharge. 'The color of your spotting is determined by the amount of time that's passed since the blood was released from the lining of the uterus,' says Jane van Dis, MD, OB-GYN, a medical advisor with menstrual company FLEX. It typically occurs on either side of your menstrual period (before your period starts in earnest or after you think it has ended), but it can happen at any point in your monthly cycle. Keep reading to learn more about how stress affects your menstrual cycle and how to manage it. How stress affects your menstrual cycle High stress levels can prompt your endocrine system to release stress hormones, including cortisol, a steroid hormone produced by your adrenal glands. The entire endocrine system is connected, and increased cortisol can have a ripple effect. When cortisol levels rise, both estrogen and testosterone can decrease. Likewise, fluctuating sex hormones can also affect your stress levels. An unexpected change in your estrogen levels can disrupt your menstrual cycle, resulting in spotting, missed menstruation, or other irregularities. 'Anything that impacts you as a person has the potential to impact the menstrual cycle and therefore cause spotting,' explains reproductive health specialist Felice Gersh, MD, author of 'PCOS SOS: A Gynecologist's Lifeline To Naturally Restore Your Rhythms, Hormones, and Happiness.' The stress may contribute to spotting if you recently experienced a life change. Causes can include changes like: a breakup moving increasing work responsibilities or losing your job a recent diagnosis, whether your own or a loved one's Stress-induced spotting is usually accompanied by other symptoms of stress, including: difficulty sleeping difficulty concentrating changes in appetite generalized fatigue muscle aches digestive upset sexual dysfunction Illnesses can also cause physical stress that may have a similar effect. How to manage stress-related spotting 'Spotting, by its name, implies that an individual is releasing a smaller amount of blood than they would during their period,' says van Dis. A panty liner should be enough to protect your underwear. If you choose to free-bleed (menstruating without blocking or collecting menstrual blood) and end up staining your underwear, blood-removal tips can help. However, if you are bleeding so much that you need a sanitary pad or tampon to catch the blood, it is likely too much to be considered spotting. You may have another type of vaginal bleeding. If the bleeding isn't from stress or your menstrual period, it's best to talk with a healthcare professional about your symptoms. Other causes of abnormal vaginal bleeding can include: pregnancy or miscarriage a growth in your uterus or cervix hormone imbalance medication changes an infection breakthrough bleeding Cycle-related changes also occur with perimenopause. This is the phase that precedes menopause. Managing stress to prevent stress-related menstrual changes Managing your overall stress levels can help reduce stress-related spotting. 'You could incorporate meditation, journaling, grounding, or nature walking into your routine,' says Gersh. Other stress reduction methods she recommends include: physical therapy massage therapy acupuncture from a licensed practitioner for myofascial release therapy, deep tissue massage, or another form of bodywork Prioritizing your overall health can also help you manage your stress levels. That means: drinking enough water eating nutrient-dense meals monitoring caffeine intake getting regular physical activity limiting alcohol, nicotine, and other substance use If you continue to feel stressed, less focused, or more irritable than usual, it may be time to talk with a mental health professional. The right therapist can help you deduce the root of your stress and give you tools to manage it. When to consult with a doctor or other healthcare professional 'If you have a regular period and this is your first time spotting, you'd be wise to rule out pregnancy as the underlying cause if there's a chance that you could be pregnant,' says Gersh. You can find out if you're pregnant by taking an at-home pregnancy test 10 or more days after you last had vaginal intercourse with a person who produces sperm. You can also ask a healthcare professional to order a blood test, which can usually detect pregnancy a few days earlier. If this is the first time you've ever spotted and there's no chance you're pregnant, Gersh says it's probably OK to assume that stress, or some other lifestyle change, is the cause. But if you're experiencing other unusual symptoms or bodily changes, she recommends consulting a healthcare professional. Frequently asked questions What does stress spotting look like? Spotting usually looks like light bleeding in your underwear. It can be pink, red, or brown and may occur with other discharge. It's typically a small amount (enough that you could use a pantyliner but not need a pad or a tampon). Spotting usually looks like light bleeding in your underwear. It can be pink, red, or brown and may occur with other discharge. It's typically a small amount (enough that you could use a pantyliner but not need a pad or a tampon). What can trigger spotting? Some possible triggers for light bleeding between periods can include stress, changing or skipping hormonal birth control, rough sex, or implantation bleeding due to pregnancy. If you have more than a small amount of blood, there could be another cause. Some possible triggers for light bleeding between periods can include stress, changing or skipping hormonal birth control, rough sex, or implantation bleeding due to pregnancy. If you have more than a small amount of blood, there could be another cause. Why am I only spotting when I wipe? If you only notice blood when you wipe after urinating, you may want to get checked out for other causes of bleeding, such as a urinary tract infection (UTI), which can cause blood in your urine.
